Global

Yesterday the HHS OIG, in collaboration with the Association of Healthcare Internal Auditors, the American Health Lawyers Association (AHLA), and the Health Care Compliance Association, released a guidance document entitled Practical Guidance for Health Care Governing Boards on Compliance Oversight (the Guidance). This publication follows two previous guidance documents published by the HHS OIG and AHLA in 2003 and 2007. Below we have summarized the top 5 takeaways from the latest guidance document. #1: Be Proactive (Avoid the Head-in-the-Sand Approach to Compliance) #2: Define Functional Roles and Relationships (Separation and Independence Matter) #3: Set and Enforce Expectations for Reporting (Tailored, …

Dès l’an prochain, les entreprises pharmaceutiques devront rendre publiques les sommes versées aux médecins. Alors que certains craignent un dérapage, d’autres y voient une mesure nécessaire. Remboursements de frais d’hébergement lors de congrès ou subventions à la recherche, les entreprises pharmaceutiques seront contraintes de publier une fois par année les sommes accordées aux professionnels de la santé, tout en précisant le nom des bénéficiaires. C’est ce que prévoit le nouveau code de coopération pharmaceutique élaboré par Scienceindustries, l’association faîtière suisse des industries chimie, pharma et biotech. L’objectif de cette nouvelle mesure est un meilleur encadrement des cadeaux et autres avantages …

Guillaume Roussel is Director of Strategy for Veeva’s data solutions in Europe. Over the course of 13 years at Cegedim, Roussel launched technology solutions designed to support the unique sales, marketing, and compliance needs of life sciences companies.

Peter John Gordon’s petition for a Scottish Sunshine Act was further considered by a parliamentary committee on the 31st March 2015. To read the full transcript

A group of transparency advocates in New Zealand has been writing various articles on the value of “more Sunshine” for a while now. Last Friday, they made their campaign more official with an editorial in the New Zealand Medical Journal. In it, a collection of five academics and doctors argue that New Zealand needs a Sunshine Act comparable to the United States. To read the article by Policy and Medicine

There is an urgent need to throw light on the financial ties between pharmaceutical companies and health practitioners in New Zealand, according to a group of health experts. New Zealand needs transparency legislation similar to the US Physician Payment Sunshine Act, according to an editorial published today (27 March) in the New Zealand Medical Journal. The editorial was written by five specialists and academics, led by Cindy Farquhar, a University of Auckland professor in obstetrics and gynaecology, and co-chair of the Cochrane Collaboration. To read the article by Denise Piper